MDMA induces Per1, Per2 and c-fos gene expression in rat suprachiasmatic nuclei

Psychopharmacology

Volumn 220, Issue 4, 2012, Pages 835-843

  Ogeil, Rowan P ^a   Kennaway, David J ^b   Salkeld, Mark D ^b   Rajaratnam, Shantha M W ^a   Broadbear, Jillian H ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Activity; Circadian; Clock genes; MDMA; Rat

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; MESSENGER RNA; PER1 PROTEIN; PER2 PROTEIN; PROTEIN C FOS; SODIUM CHLORIDE; CIRCADIAN RHYTHM SIGNALING PROTEIN; PER1 PROTEIN, RAT; PER2 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CIRCADIAN RHYTHM; CONTROLLED STUDY; GENE EXPRESSION; GENE INDUCTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C FOS; PER1 GENE; PER2 GENE; PRIORITY JOURNAL; RAT; SUPRACHIASMATIC NUCLEUS; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LONG EVANS RAT; METABOLISM; ONCOGENE; PHYSIOLOGY;

ANIMALS; CIRCADIAN RHYTHM; GENE EXPRESSION REGULATION; GENES, FOS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PERIOD CIRCADIAN PROTEINS; RATS; RATS, LONG-EVANS; SUPRACHIASMATIC NUCLEUS;

EID: 84871854425     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2541-8     Document Type: Article

References (55)

1. Agostino PV, Plano SA, Golombek D.A. (2007) Sildenafil accelerates re-entrainment of circadian rhythms after advancing light schedules. Proc Natl Acad Sci USA 104:9834-9839
2. Albrecht U (2002) Functional genomics of sleep and circadian rhythms: invited review: regulation of mammalian circadian clock genes. J Appl Physiol 92:1348-1355
3. Allen RP, McCann UD, Ricaurte G.A. (1993) Persistent effects of (+-) 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") on human sleep. Sleep 16:560-564
4. Balogh B, Molnar E, Jakus R., Quate L, Olverman HJ, Kelly PAT et al (2004) Effects of a single dose of 3,4-methylenedioxymetham-phetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA. Psychophar-macology 173:296-309
5. Biello SM, Dafters R.I. (2001) MDMA and fenfluramine alter the response of the circadian clock to a serotonergic agonist in vitro. Brain Res 920:202-209
6. Carhart-Harris R.L., Nutt DJ, Munafo M, Wilson S.J. (2009) Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study. J Psychopharmacol 23:249-257
7. Challet E (2007) Minireview: entrainment of the suprachiasmatic clockwork in diurnal and nocturnal mammals. Endocrinology 148:5648-5655
8. Colbron S, Jones M, Biello S.M. (2002) MDMA alters the response of the circadian clock to a photic and non-photic stimulus. Brain Res 956:45-52
9. Cuesta M, Clesse D, Pévet P, Challet E. (2009) New light on the serotonergic paradox in the rat circadian system. J Neurochem 110:231-243
10. Cutrera RA, Saboureau M, Pévet P (1996) Phase-shifting effect of 8-OH-DPAT, a 5-HT1A/5-HT7 receptor agonist, on locomotor activity in golden hamster in constant darkness. Neurosci Lett 210:1-4
11. Dardente H, Cermakian N. (2007) Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol Int 24:195-213
12. Dijk DJ, Czeisler C.A. (1995) Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans. J Neurosci 15:3526-3538
13. Dudley TE, Dinardo LA, Glass J.D. (1999) In vivo assessment of the midbrain Raphe nuclear regulation of serotonin release in the hamster suprachiasmatic nucleus. J Neurophysiol 81:1469-1477
14. Edgar DM, Miller JD, Prosser R.A., Dean RR, Dement W.C. (1993) Serotonin and the mammalian circadian system: II. Phase-shifting rat behavioral rhythms with serotonergic agonists. J Biol Rhythms 8:17-37
15. Gardani M, Blance RN, Biello S.M. (2005) MDMA alters the response of the mammalian circadian clock in hamsters: effects on re-entrainment and triazolam-induced phase shifts. Brain Res 1046:105-115
16. 3 receptor-mediated photic-like responses of the circadian clock in the rat. Neuropharmacology 52:662-671
17. Horikawa K, Shibata S. (2004) Phase-resetting response to (+) 8-OH-DPAT, a serotonin (1A/7) receptor agonist, in the mouse in vivo. Neurosci Lett 368:130-134
18. Huxster J (2006) The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans. J Psychopharmacol 20:281-290
19. Johansson C, Willeit M, Smedh C., Ekholm J, Paunio T, Kieseppa T et al (2003) Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 28:734-739
20. Jones KA, Callen F, Blagrove M.T., Parrott A.C. (2008) Sleep, energy and self rated cognition across 7 nights following recreational Ecstasy/MDMA use. Sleep Hypn 10:16-28
21. Kennaway DJ (2004) Resetting the suprachiasmatic nucleus clock. Front Biosci 9:56-62
22. Kennaway DJ (2010) Review: clock genes at the heart of depression. J Psychopharmacol 24:5-14
23. 2c agonists mimic the effect of light pulses on circadian rhythms. Brain Res 806:257-270
24. Kennaway DJ, Rowe SA, Ferguson S.A. (1996) Serotonin agonists mimic the phase shifting effects of light on the melatonin rhythm in rats. Brain Res 737:301-307
25. Kohler M, Kalkowski A, Wollnik F. (1999) Serotonin agonist quipazine induces photic-like phase shifts of the circadian activity rhythm and c-Fos expression in the rat suprachiasmatic nucleus. J Biol Rhythms 14:131-140
26. Liechti ME, Vollenweider F.X. (2000) The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers. J Psychopharmacol 14:269-274
27. Livak KJ, Schmittgen T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-[delta][delta]CT method. Methods 25:402-408
28. McCann U, Ricaurte G. (2007) Effects of (+-)3,4-methylenedioxyme- tamphetamine (MDMA) on sleep and circadian rhythms. Sci World J 7:231-238
29. McCann UD, Eligulashvili V, Ricaurte G.A. (2000) (+-)3,4-Methyl- enedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies. Neuropsychobiology 42:11-16
30. McGregor IS, Clemens KJ, Van der Plasse G, Li KM, Hunt GE, Chen F et al (2003) Increased anxiety 3 months after brief exposure to MDMA ('Ecstasy') in rats: association with altered 5-HT transporter and receptor density. Neuropsychopharmacology 28:1472-1484
31. Mistlberger RE (1991) Effects of daily schedules of forced activity on free-running rhythms in the rat. J Biol Rhythms 6:71-80
32. Mistlberger RE, Antle MC, Glass J.D., Miller J.D. (2000) Behavioral and serotonergic regulation of circadian rhythms. Biol Rhythm Res 31:240-283
33. Moore RY (2003) Circadian timing. In: Squire LR, Bloom FE, McConnell SK, Roberts JL, Spitzer NC, Zigmond MJ (eds) Fundamental neuroscience. Elsevier, California
34. Moore RY, Eichler V.B. (1972) Loss of a circadian adrenal corticoste-rone rhythm following suprachiasmatic lesions in the rat. Brain Res 42:201-206
35. Montgomery C, Fisk JE, Wareing M, Murphy P. (2007) Self reported sleep quality and cognitive performance in ecstasy users. Hum Psychopharmacol 22:537-548
36. Mrosovsky N (1996) Locomotor activity and non-photic influences on circadian clocks. Biol Rev 71:343-372
37. Nichols DE (1986) Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens-identification of a new therapeutic class-entactogens. J Psychoactive Drugs 18:305-313
38. Oberlender R, Nichols D.E. (1990) (+)-N-methyl-1-(1,3-benzodioxol-5-yl)- 2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy- methamphetamine-like behavioral activity. J Pharmacol Exp Ther 255:1098-1106
39. Ogeil RP, Rajaratnam SMW, Redman JR, Broadbear J.H. (2010) Acute MDMA administration alters the distribution and circadian rhythm of wheel running activity in the rat. Brain Res 1359:128-136
40. Ogeil RP, Rajaratnam SMW, Broadbear J.H. (2011) Ecstasy and sleep disturbance: progress towards elucidating a role for the circadian system. Sleep Biol Rhythms. Accepted 1st July, 2011. doi:10.1111/j.1479-8425.2011.00510.x
41. Parks KA, Kennedy C.L. (2004) Club drugs: reasons for and consequences of use. J Psychoactive Drugs 36:295-302
42. Randall S, Johanson CE, Tancer M, Roehrs T. (2009) Effects of acute 3, 4-methylenedioxymethamphetamine on sleep and daytime sleepiness in MDMA users: a preliminary study. Sleep 32:1513-1519
43. Reppert SM, Weaver D.R. (2001) Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63:647-676
44. Reppert SM, Weaver D.R. (2002) Coordination of circadian timing in mammals. Nature 418:935-941
45. Schuhler S, Saboureau M, Pitrosky B., Pévet P (1998) In Syrian hamsters, 5-HT fibres within the suprachiasmatic nuclei are necessary for the expression of 8-OH-DPAT induced phase-advance of locomotor activity rhythm. Neurosci Lett 256:33-36
46. Stephan FK, Zucker I. (1972) Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci USA 69:1583-1586
47. Stephan FK, Berkley KJ, Moss R.L. (1981) Efferent connections of the rat suprachiasmatic nucleus. Neuroscience 6:2625-2641
48. Varcoe TJ, Kennaway D.J. (2008) Activation of 5-HT2C receptors acutely induces Per1 gene expression in the rat SCN in vitro. Brain Res 1209:19-28
49. 2C receptors acutely induces per gene expression in the rat supra-chiasmatic nucleus at night. Mol Brain Res 119:192-200
50. Verheyden SL, Hadfield J, Calin T., Curran H.V. (2002) Sub-acute effects of MDMA (+-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences. Psycho-pharmacology 161:23-31
51. Wallace TL, Gudelsky GA, Vorhees C.V. (2001) Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxyme-thamphetamine. Psychopharmacology 153:321-326
52. Weaver D (1998) The suprachiasmatic nucleus: a 25-year retrospective. J Biol Rhythms 13:100-112
53. Wirz-Justice A (2003) Chronobiology and mood disorders. Dialogues Clin Neurosci 5:315-325
54. Wirz-Justice A (2006) Biological rhythm disturbances in mood disorders. Int Clin Psychopharmacol 21:S11-S15
55. Xie T, Tong L, McLane M.W., Hatzidimitriou G., Yuan J, McCann U et al (2006) Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines. Neuropsychopharmacology 31:2639-2651